218 related articles for article (PubMed ID: 37285598)
1. Hyperuricemia as an independent risk factor for metabolic dysfunction-associated fatty liver disease in nonobese patients without type 2 diabetes mellitus.
Liu J; Wang C; Wang YT; Liu JX; Zhou TH; Yao SK; Chen G
Am J Physiol Endocrinol Metab; 2023 Jul; 325(1):E62-E71. PubMed ID: 37285598
[TBL] [Abstract][Full Text] [Related]
2. Association of Uric Acid to Creatinine Ratio with Metabolic Dysfunction-Associated Fatty Liver in Non-Obese Individuals Without Type 2 Diabetes Mellitus.
Liu J; Wang C; Wang Y; Yao S
Diabetes Metab Syndr Obes; 2024; 17():131-142. PubMed ID: 38222031
[TBL] [Abstract][Full Text] [Related]
3. [Associations between serum GDF15 and glycolipid metabolism disorder in metabolic associated fatty liver patients].
Li X; Yu XM; Li EH; Chen PH; Zheng LM; Zhang S
Zhonghua Nei Ke Za Zhi; 2023 Aug; 62(8):987-992. PubMed ID: 37528037
[No Abstract] [Full Text] [Related]
4. Prevalence, characteristics, and mortality outcomes of obese and nonobese MAFLD in the United States.
Dao AD; Nguyen VH; Ito T; Cheung R; Nguyen MH
Hepatol Int; 2023 Feb; 17(1):225-236. PubMed ID: 36309601
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of and risk factors for metabolic associated fatty liver disease in an urban population in China: a cross-sectional comparative study.
Chen YL; Li H; Li S; Xu Z; Tian S; Wu J; Liang XY; Li X; Liu ZL; Xiao J; Wei JY; Ma CY; Wu KN; Ran L; Kong LQ
BMC Gastroenterol; 2021 May; 21(1):212. PubMed ID: 33971822
[TBL] [Abstract][Full Text] [Related]
6. Association of metabolic dysfunction-associated fatty liver disease with chronic kidney disease: a Chinese population-based study.
Hu Q; Chen Y; Bao T; Huang Y
Ren Fail; 2022 Dec; 44(1):1996-2005. PubMed ID: 36374233
[TBL] [Abstract][Full Text] [Related]
7. Correlation between serum uric acid and body fat distribution in patients with MAFLD.
Tao M; Liu J; Chen X; Wang Q; He M; Chen W; Wang C; Zhang L
BMC Endocr Disord; 2023 Sep; 23(1):204. PubMed ID: 37749567
[TBL] [Abstract][Full Text] [Related]
8. Optimum non-invasive predictive indicators for metabolic dysfunction-associated fatty liver disease and its subgroups in the Chinese population: A retrospective case-control study.
Liu J; Duan S; Wang C; Wang Y; Peng H; Niu Z; Yao S
Front Endocrinol (Lausanne); 2022; 13():1035418. PubMed ID: 36531447
[TBL] [Abstract][Full Text] [Related]
9. Metabolic characteristics of non-obese and obese metabolic dysfunction-associated fatty liver disease in type 2 diabetes mellitus and its association with diabetic peripheral neuropathy and diabetic retinopathy.
Dang SW; Gao L; Li YJ; Zhang R; Xu J
Front Med (Lausanne); 2023; 10():1216412. PubMed ID: 37828942
[TBL] [Abstract][Full Text] [Related]
10. [Association of elevated uric acid with metabolic disorders and analysis of the risk factors of hyperuricemia in type 2 diabetes mellitus].
WU D; LIU H; LI SH
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Mar; 31(3):544-7. PubMed ID: 21421503
[TBL] [Abstract][Full Text] [Related]
11. Associations of sex-related and thyroid-related hormones with risk of metabolic dysfunction-associated fatty liver disease in T2DM patients.
Lu W; Li S; Li Y; Zhou J; Wang K; Chen N; Li Z
BMC Endocr Disord; 2024 Jun; 24(1):84. PubMed ID: 38849804
[TBL] [Abstract][Full Text] [Related]
12. Predictive Value of the Chinese Visceral Adiposity Index for Metabolic Dysfunction-Associated Fatty Liver Disease and Elevated Alanine Aminotransferase Levels in Nonobese Chinese Adults: A Cross-Sectional Study.
Niu Z; Chen J; Wang H; Wang R; Peng H; Duan S; Yao S
J Inflamm Res; 2024; 17():3893-3913. PubMed ID: 38915805
[TBL] [Abstract][Full Text] [Related]
13. Blood lactate levels are associated with an increased risk of metabolic dysfunction-associated fatty liver disease in type 2 diabetes: a real-world study.
Ma YL; Ke JF; Wang JW; Wang YJ; Xu MR; Li LX
Front Endocrinol (Lausanne); 2023; 14():1133991. PubMed ID: 37223022
[TBL] [Abstract][Full Text] [Related]
14. Metabolic Dysfunction-Associated Fatty Liver Disease in Newly Diagnosed, Treatment-Naive Hypertensive Patients and Its Association with Cardiorenal Risk Markers.
Theofilis P; Vordoni A; Tsimihodimos V; Kalaitzidis RG
High Blood Press Cardiovasc Prev; 2023 Jan; 30(1):63-72. PubMed ID: 36626077
[TBL] [Abstract][Full Text] [Related]
15. Correlation between remnant cholesterol and hyperuricemia in patients with type 2 diabetes mellitus: a cross-sectional study.
Lin H; Xu J; Teng C
Lipids Health Dis; 2024 May; 23(1):155. PubMed ID: 38796430
[TBL] [Abstract][Full Text] [Related]
16. Correlations between blood uric acid and the incidence and progression of type 2 diabetes nephropathy.
Li GX; Jiao XH; Cheng XB
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):506-511. PubMed ID: 29424910
[TBL] [Abstract][Full Text] [Related]
17. J-Shaped Relationship Between Serum Prolactin and Metabolic-Associated Fatty Liver Disease in Female Patients With Type 2 Diabetes.
Zhu C; Ma H; Huang D; Li G; Gao J; Cai M; You H; Bu L; Qu S
Front Endocrinol (Lausanne); 2022; 13():815995. PubMed ID: 35222274
[TBL] [Abstract][Full Text] [Related]
18. Metabolic (Dysfunction)-Associated Fatty Liver Disease in Chinese Patients with Type 2 Diabetes from a Subcenter of the National Metabolic Management Center.
Guan C; Fu S; Zhen D; Yang K; An J; Wang Y; Ma C; Jiang N; Zhao N; Liu J; Yang F; Tang X
J Diabetes Res; 2022; 2022():8429847. PubMed ID: 35127953
[TBL] [Abstract][Full Text] [Related]
19. Type 2 diabetes mellitus in metabolic-associated fatty liver disease vs. type 2 diabetes mellitus non-alcoholic fatty liver disease: a longitudinal cohort analysis.
Muthiah M; Ng CH; Chan KE; Fu CE; Lim WH; Tan DJH; Nah B; Kong G; Xiao J; Yong JN; Tan B; Syn N; Wang JW; Sayed N; Tan E; Chew NW; Dan YY; Siddiqui MS; Sanyal AJ; Noureddin M
Ann Hepatol; 2023; 28(1):100762. PubMed ID: 36182031
[TBL] [Abstract][Full Text] [Related]
20. Metabolomics to identify fingerprints of carotid atherosclerosis in nonobese metabolic dysfunction-associated fatty liver disease.
Shao C; Xu L; Lei P; Wang W; Feng S; Ye J; Zhong B
J Transl Med; 2023 Jan; 21(1):12. PubMed ID: 36624524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
